Abstract
Adherence to treatment is a major determinant of outcome in bipolar disorder. Poor insight, attitudes towards treatment, and poor understanding of medications and the illness can all lead to reduced adherence. Nonadherence and partial adherence both also appear to play a significant role in relapse and recurrence. Clinicians can address the problem of poor adherence by ensuring medication administration. Assured administration can be accomplished with long-acting atypical antipsychotic medications. Case series and naturalistic trials utilizing first generation antipsychotics suggest that depot antipsychotics are effective in reducing relapse in bipolar illness. Controlled studies with second generation agents confirm this impression. Depot antipsychotics, including long-acting first- and second-generation agents, can be important adjuncts in the long-term management of bipolar illness.
Keywords: Antipsychotic medications, Assured administration, Bipolar disorder, Depot, Intramuscular injection.
Current Drug Delivery
Title:Adherence and Assured Administration of Medications in Bipolar Patients
Volume: 10 Issue: 6
Author(s): Peggy L. El-Mallakh and Rif S. El-Mallakh
Affiliation:
Keywords: Antipsychotic medications, Assured administration, Bipolar disorder, Depot, Intramuscular injection.
Abstract: Adherence to treatment is a major determinant of outcome in bipolar disorder. Poor insight, attitudes towards treatment, and poor understanding of medications and the illness can all lead to reduced adherence. Nonadherence and partial adherence both also appear to play a significant role in relapse and recurrence. Clinicians can address the problem of poor adherence by ensuring medication administration. Assured administration can be accomplished with long-acting atypical antipsychotic medications. Case series and naturalistic trials utilizing first generation antipsychotics suggest that depot antipsychotics are effective in reducing relapse in bipolar illness. Controlled studies with second generation agents confirm this impression. Depot antipsychotics, including long-acting first- and second-generation agents, can be important adjuncts in the long-term management of bipolar illness.
Export Options
About this article
Cite this article as:
El-Mallakh L. Peggy and El-Mallakh S. Rif, Adherence and Assured Administration of Medications in Bipolar Patients, Current Drug Delivery 2013; 10 (6) . https://dx.doi.org/10.2174/156720181006131125152802
DOI https://dx.doi.org/10.2174/156720181006131125152802 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Trends in Fiber-Optic Chemical and Biological Sensors
Current Analytical Chemistry Glycerolipid Acyltransferases in Triglyceride Metabolism and Energy Homeostasis-Potential as Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets Nutritional Requirements for Maternal and Newborn Health
Current Women`s Health Reviews Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry The Economic Costs for the Control of Cardiovascular Risk: An Overview
Current Pharmaceutical Design Food Addiction and Neuroimaging
Current Pharmaceutical Design Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Malaria-induced Alterations of Drug Kinetics and Metabolism in Rodents and Humans
Current Drug Metabolism Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Current Medicinal Chemistry - Anti-Cancer Agents Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment
Current Neuropharmacology Functional Genomics- and Network-driven Systems Biology Approaches for Pharmacogenomics and Toxicogenomics
Current Drug Metabolism Effects of Polymorphisms of the CYP450 Enzyme Genes on Estrogen Status and the Risk for Osteoporosis
Current Pharmacogenomics Gender Specific Aspects of Cell Death in the Cardiovascular System
Current Pharmaceutical Design Cardiovascular Effects of Losartan and Its Relevant Clinical Application
Current Medicinal Chemistry Thyroid Hormone Modulation of Immunity: Its Participation in Chronic Stress-Induced Immune Alterations
Current Immunology Reviews (Discontinued) Therapies for Neurological Disease in the Mucopolysaccharidoses
Current Gene Therapy MicroRNAs: Regulators of TLR2-Mediated Probiotic Immune Responses
MicroRNA SNP Technologies for Drug Discovery: A Current Review
Current Drug Discovery Technologies Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design